CUTAQUIG Trademark

Trademark Overview

On Thursday, November 3, 2016, a trademark application was filed for CUTAQUIG with the United States Patent and Trademark Office. The USPTO has given the CUTAQUIG trademark a serial number of 87225330. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, December 13, 2025. This trademark is owned by Octapharma AG. The CUTAQUIG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, in particular medicines containing immunoglobulins extracted from blood plasma for injections
cutaquig

General Information

Serial Number87225330
Word MarkCUTAQUIG
Filing DateThursday, November 3, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, December 13, 2025
Registration Number5880441
Registration DateTuesday, October 8, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 13, 2017

Trademark Statements

Goods and ServicesPharmaceutical products, in particular medicines containing immunoglobulins extracted from blood plasma for injections
Translation of Words in MarkThe wording "CUTAQUIG" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 8, 2016
Primary Code005
First Use Anywhere DateTuesday, April 30, 2019
First Use In Commerce DateTuesday, April 30, 2019

Trademark Owner History

Party NameOctapharma AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLachen CH-8853
CH
Party NameOctapharma AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLachen CH-8853
CH
Party NameOctapharma AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLachen CH-8853
CH

Trademark Events

Event DateEvent Description
Monday, November 7, 2016NEW APPLICATION ENTERED
Tuesday, November 8, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 10, 2017ASSIGNED TO EXAMINER
Monday, February 13, 2017NON-FINAL ACTION WRITTEN
Monday, February 13, 2017NON-FINAL ACTION E-MAILED
Monday, February 13, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 28, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 12, 2017ASSIGNED TO LIE
Friday, April 14, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 14, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 17, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 9, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 24, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 13, 2017PUBLISHED FOR OPPOSITION
Tuesday, June 13, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 8, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 18, 2018SOU TEAS EXTENSION RECEIVED
Thursday, January 18, 2018SOU EXTENSION 1 FILED
Thursday, January 18, 2018SOU EXTENSION 1 GRANTED
Saturday, January 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 6, 2018SOU TEAS EXTENSION RECEIVED
Monday, August 6, 2018SOU EXTENSION 2 FILED
Monday, August 6, 2018SOU EXTENSION 2 GRANTED
Wednesday, August 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 8, 2019SOU TEAS EXTENSION RECEIVED
Friday, February 8, 2019SOU EXTENSION 3 FILED
Friday, February 8, 2019SOU EXTENSION 3 GRANTED
Tuesday, February 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 2, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, August 29, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 2, 2019USE AMENDMENT FILED
Thursday, August 29, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 3, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 4, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 8, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, June 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 8, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 9, 2025TEAS SECTION 8 & 15 RECEIVED
Saturday, December 13, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, December 13, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, December 13, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

cutaquig from blood plasma injections extracted immunoglobulins products particular medicines containing